Brigatinib

Brigatinib is a second-generation ALK tyrosine kinase inhibitor used for ALK-positive non-small cell lung cancer, including after progression on earlier ALK inhibitors. Simson Pharma's Brigatinib reference standard and impurities support stability-indicating method development for this targeted oncology agent.

Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) supply high-quality Brigatinib Reference Standards, pharmacopoeial reference materials, and its related impurities to pharmaceutical manufacturers, CROs, analytical laboratories, universities, and regulatory organizations worldwide. To service the Europe and America market efficiently, Simson Pharma Limited has set up Simson Pharma Global Ltd. in United Kingdom and Simson Pharma Global LLC in USA respectively.

Pharmaceutical Reference Standards / Impurity Standards

Brigatinib
Brigatinib
  • CAT. No.B1030000
  • CAS. No.1197953-54-0
  • Mol. F.C29H39ClN7O2P
  • Mol. W.584.09 g/mol
  • Stock Status:Instock
Product View
Product Compare
Brigatinib Nitroso Impurity 1
Brigatinib Nitroso Impurity 1
  • CAT. No.B1030002
  • CAS. No.NA
  • Mol. F.C29H38ClN8O3P
  • Mol. W.613.09 g/mol
  • Stock Status:Custom Synthesis
Product View
Product Compare
Brigatinib Nitroso Impurity 2
Brigatinib Nitroso Impurity 2
  • CAT. No.B1030003
  • CAS. No.NA
  • Mol. F.C29H38ClN8O3P
  • Mol. W.613.09 g/mol
  • Stock Status:Custom Synthesis
Product View
Product Compare
Brigatinib Nitroso Impurity 3
Brigatinib Nitroso Impurity 3
  • CAT. No.B1030004
  • CAS. No.NA
  • Mol. F.C29H37ClN9O4P
  • Mol. W.642.10 g/mol
  • Stock Status:Custom Synthesis
Product View
Product Compare
5-Methyl Brigatinib
5-Methyl Brigatinib
  • CAT. No.B1030005
  • CAS. No.1197961-02-6
  • Mol. F.C30H41ClN7O2P
  • Mol. W.598.12 g/mol
  • Stock Status:Custom Synthesis
Product View
Product Compare
Brigatinib Impurity 1
Brigatinib Impurity 1
  • CAT. No.B1030006
  • CAS. No.1197959-30-0
  • Mol. F.C24H29ClN5O3P
  • Mol. W.501.95 g/mol
  • Stock Status:Custom Synthesis
Product View
Product Compare
Brigatinib Impurity 2
Brigatinib Impurity 2
  • CAT. No.B1030007
  • CAS. No.1259274-28-6
  • Mol. F.C21H28Cl2N6O
  • Mol. W.451.39 g/mol
  • Stock Status:Custom Synthesis
Product View
Product Compare
Demethyl Brigatinib
Demethyl Brigatinib
  • CAT. No.B1030008
  • CAS. No.1197958-75-0
  • Mol. F.C28H37ClN7O2P
  • Mol. W.570.07 g/mol
  • Stock Status:Custom Synthesis
Product View
Product Compare
O Ethyl Brigatinib
O Ethyl Brigatinib
  • CAT. No.B1030009
  • CAS. No.1197960-18-1
  • Mol. F.C30H41ClN7O2P
  • Mol. W.598.12 g/mol
  • Stock Status:Custom Synthesis
Product View
Product Compare
Brigatinib Impurity 3
Brigatinib Impurity 3
  • CAT. No.B1030010
  • CAS. No.1197953-49-3
  • Mol. F.C12H12Cl2N3OP
  • Mol. W.316.12 g/mol
  • Stock Status:Custom Synthesis
Product View
Product Compare

Isotope Labelled Compounds

Brigatinib D6
Brigatinib D6
  • CAT. No.B1030001
  • CAS. No.NA
  • Mol. F.C29H33D6ClN7O2P
  • Mol. W.590.13 g/mol
  • Stock Status:Instock
Product View
Product Compare
Brigatinib D11
Brigatinib D11
  • CAT. No.B1030014
  • CAS. No.2055306-76-6
  • Mol. F.C29H28D11ClN7O2P
  • Mol. W.595.16 g/mol
  • Stock Status:Please Enquire
Product View
Product Compare